Saturday 17 October 2026
Export USNA’s income statement to Excel — free account
USANA Health Sciences, Inc.
USNA Consumer Defensive Packaged Foods
USANA Health Sciences, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $925.3 million, up 8.28% from fiscal 2024. In the quarter to June 2026, revenue fell 5.33%, EPS fell 323.1% and free cash flow grew 180.6%, each against the same quarter a year earlier.
15.54
0.16
+1.04%
Follow USNA
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
Piotroski F-Score |
5 | 6 | 7 | 5 |
+8 more TTM periods Free account |
| (4.19%) | 1.65% | 2.02% | 3.20% | ||
| (3.08%) | 1.19% | 1.44% | 2.43% | ||
ROIC |
(0.19%) | 5.85% | 6.24% | 6.83% | |
Return on Tangible Assets |
(8.22%) | 3.27% | 4.23% | 7.03% | |
Average Days of Receivables |
1.33 | 3.81 | 1.69 | 0.00 | |
Free Cash Flow per Share |
1.08 | 0.38 | 0.67 | 1.02 | |
Free Cash Flow |
19.90 | 6.91 | 12.43 | 18.69 | |
Capital Expenditures |
(7.82) | (9.71) | (9.92) | (12.83) | |
| Other line items | |||||
Cash ROIC |
2.86% | 0.98% | 1.80% | 2.78% | |
Accounts Receivable Turnover |
173.97 | 108.44 | 141.83 | 0.00 | |
Accounts Payable Turnover |
12.36 | 13.76 | 13.73 | 16.34 | |
Inventory Turnover |
2.43 | 2.45 | 2.33 | 2.46 | |
Average Days of Payables |
27.34 | 28.50 | 31.37 | 31.16 | |
Days of Inventory on Hand |
152.99 | 169.22 | 186.47 | 174.40 | |
Tax Rate |
(12.53) | (0.77) | (0.72) | (0.63) | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
73.61% | 72.95% | 73.49% | 74.60% | |
Share Based Compensation of Revenue |
1.55% | 1.56% | 1.49% | 1.50% | |
Interest Coverage |
— | 53.11 | 44.46 | 49.32 | |
Operating CF/Net income |
(1.25) | 1.87 | 2.08 | 1.86 | |
Depreciation/Fixed assets |
0.72 | 0.41 | 0.42 | 0.37 | |
Capex/Depreciation |
(0.12) | (0.25) | (0.25) | (0.36) | |
Revenue per Share |
49.41 | 50.33 | 49.92 | 49.89 | |
Operating CF per Share |
1.50 | 0.90 | 1.21 | 1.72 | |
Capex per Share |
(0.42) | (0.53) | (0.54) | (0.70) | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.01 |
Columns are period end dates